Actinogen Board Changes
Filed with ASX · · 1 page · English
SYDNEY, 18 December 2014: The Board of Actinogen Limited (Actinogen Medical, ASX:ACW) , an Australian biotechnology company focused on the development of novel treatments for Alzheimer’s disease and other major age-related neurodegenerative disorders, is pleased to announce the appointment of Dr Bill Ketelbey as a Managing Director of the Company. In other Board changes, current Non-Executive Dire
Actinogen Medical Limited on 6ix
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical